rhil 2 (Chiron Corporation)
86
Structured Review
Chiron Corporation
rhil 2
Rhil 2, supplied by Chiron Corporation, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rhil-2/2+rhil/us12533338-31-16-18
Average 86 stars, based on 1 article reviews
Rhil 2, supplied by Chiron Corporation, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rhil-2/2+rhil/us12533338-31-16-18
Average 86 stars, based on 1 article reviews
rhil 2 - by Bioz Stars,
2026-09
86/100 stars
Images
Related Articles
In Vitro:Article Title: Evolution of melanoma cross-resistance to CD8 + T cells and MAPK inhibition in the course of BRAFi treatment Article Snippet: Expansion of TILs was achieved by culturing suspension cells from tumor tissue in RPMI 1640 supplemented with 10% Article Title: The IL-2 SYNTHORIN molecule promotes functionally adapted Tregs in a preclinical model of type 1 diabetes. Article Snippet: To investigate the in vitro effects of SAR’336 (Sanofi) on Tregs, purified CD4+GFP+ Tregs (GFP+, 50 × 103) from B6.FoxP3GFPki female mice were activated in 96-well, flat-bottomed (0.2 mL) plates previously coated with α-CD3 (3 μg/mL) and α-CD28 (2 μg/mL), in the presence of Article Title: The IL-2 SYNTHORIN molecule promotes functionally adapted Tregs in a preclinical model of type 1 diabetes Article Snippet: To investigate the in vitro effects of SAR’336 (Sanofi) on Tregs, purified CD4 + GFP + Tregs (GFP + , 50 × 10 3 ) from B6.FoxP3 GFPki female mice were activated in 96-well, flat-bottomed (0.2 mL) plates previously coated with α-CD3 (3 μg/mL) and α-CD28 (2 μg/mL), in the presence of Article Title: Genetically engineered macrophages persist in solid tumors and locally deliver therapeutic proteins to activate immune responses Article Snippet: T cells were stimulated with Dynabeads and cultured in RPMI-1640 (Gibco) with 10% FBS (VWR Seradigm), 2 mM l-glutamine (Gibco), 0.5 ng/mL rhIL-15 (Miltenyi Biotec) and either 50 U/mL Article Title: Cancer-Initiating Cells from Colorectal Cancer Patients Escape from T Cell–Mediated Immunosurveillance In Vitro through Membrane-Bound IL-4 Article Snippet: IL-4 neutralization can augment the proliferation of MLTCs stimulated with autologous CICs Isolation of CRC-reactive T lymphocytes PBMCs from the peripheral blood of CRC patients (#1076, 1247, and 14583) were cultured in vitro in the presence of autologous irradiated (300 Gy) colorectal CICs or, when available, FBS tumor cells, pretreated or not with rhIFN-γ (1000 IU/ml; PeproTech), with 100 IU/ml Article Title: Cancer-Initiating Cells from Colorectal Cancer Patients Escape from T Cell–Mediated Immunosurveillance In Vitro through Membrane-Bound IL-4 Article Snippet: PBMCs from the peripheral blood of CRC patients (#1076, 1247, and 14583) were cultured in vitro in the presence of autologous irradiated (300 Gy) colorectal CICs or, when available, FBS tumor cells, pretreated or not with rhIFN-γ (1000 IU/ml; PeproTech), with 100 IU/ml Article Title: Genetically engineered macrophages persist in solid tumors and locally deliver therapeutic proteins to activate immune responses. Article Snippet: T cells were stimulated with Dynabeads and cultured in RPMI-1640 (Gibco) with 10% FBS (VWR Seradigm), 2 mM l- glutamine (Gibco), 0.5 ng/mL rhIL-15 (Miltenyi Biotec) and either 50 U/ mL Article Title: Modulation of SRSF2 expression reverses the exhaustion of TILs via the epigenetic regulation of immune checkpoint molecules Article Snippet: In brief, a single tumor fragment was placed in individual wells of a Purification:Article Title: Evolution of melanoma cross-resistance to CD8 + T cells and MAPK inhibition in the course of BRAFi treatment Article Snippet: Expansion of TILs was achieved by culturing suspension cells from tumor tissue in RPMI 1640 supplemented with 10% Article Title: The IL-2 SYNTHORIN molecule promotes functionally adapted Tregs in a preclinical model of type 1 diabetes. Article Snippet: To investigate the in vitro effects of SAR’336 (Sanofi) on Tregs, purified CD4+GFP+ Tregs (GFP+, 50 × 103) from B6.FoxP3GFPki female mice were activated in 96-well, flat-bottomed (0.2 mL) plates previously coated with α-CD3 (3 μg/mL) and α-CD28 (2 μg/mL), in the presence of Article Title: The IL-2 SYNTHORIN molecule promotes functionally adapted Tregs in a preclinical model of type 1 diabetes Article Snippet: To investigate the in vitro effects of SAR’336 (Sanofi) on Tregs, purified CD4 + GFP + Tregs (GFP + , 50 × 10 3 ) from B6.FoxP3 GFPki female mice were activated in 96-well, flat-bottomed (0.2 mL) plates previously coated with α-CD3 (3 μg/mL) and α-CD28 (2 μg/mL), in the presence of Article Title: Genetically engineered macrophages persist in solid tumors and locally deliver therapeutic proteins to activate immune responses Article Snippet: T cells were stimulated with Dynabeads and cultured in RPMI-1640 (Gibco) with 10% FBS (VWR Seradigm), 2 mM l-glutamine (Gibco), 0.5 ng/mL rhIL-15 (Miltenyi Biotec) and either 50 U/mL Article Title: Cancer-Initiating Cells from Colorectal Cancer Patients Escape from T Cell–Mediated Immunosurveillance In Vitro through Membrane-Bound IL-4 Article Snippet: IL-4 neutralization can augment the proliferation of MLTCs stimulated with autologous CICs Isolation of CRC-reactive T lymphocytes PBMCs from the peripheral blood of CRC patients (#1076, 1247, and 14583) were cultured in vitro in the presence of autologous irradiated (300 Gy) colorectal CICs or, when available, FBS tumor cells, pretreated or not with rhIFN-γ (1000 IU/ml; PeproTech), with 100 IU/ml Article Title: Cancer-Initiating Cells from Colorectal Cancer Patients Escape from T Cell–Mediated Immunosurveillance In Vitro through Membrane-Bound IL-4 Article Snippet: PBMCs from the peripheral blood of CRC patients (#1076, 1247, and 14583) were cultured in vitro in the presence of autologous irradiated (300 Gy) colorectal CICs or, when available, FBS tumor cells, pretreated or not with rhIFN-γ (1000 IU/ml; PeproTech), with 100 IU/ml Article Title: Genetically engineered macrophages persist in solid tumors and locally deliver therapeutic proteins to activate immune responses. Article Snippet: T cells were stimulated with Dynabeads and cultured in RPMI-1640 (Gibco) with 10% FBS (VWR Seradigm), 2 mM l- glutamine (Gibco), 0.5 ng/mL rhIL-15 (Miltenyi Biotec) and either 50 U/ mL Article Title: Modulation of SRSF2 expression reverses the exhaustion of TILs via the epigenetic regulation of immune checkpoint molecules Article Snippet: In brief, a single tumor fragment was placed in individual wells of a Labeling:Article Title: Evolution of melanoma cross-resistance to CD8 + T cells and MAPK inhibition in the course of BRAFi treatment Article Snippet: Expansion of TILs was achieved by culturing suspension cells from tumor tissue in RPMI 1640 supplemented with 10% Article Title: The IL-2 SYNTHORIN molecule promotes functionally adapted Tregs in a preclinical model of type 1 diabetes. Article Snippet: To investigate the in vitro effects of SAR’336 (Sanofi) on Tregs, purified CD4+GFP+ Tregs (GFP+, 50 × 103) from B6.FoxP3GFPki female mice were activated in 96-well, flat-bottomed (0.2 mL) plates previously coated with α-CD3 (3 μg/mL) and α-CD28 (2 μg/mL), in the presence of Article Title: The IL-2 SYNTHORIN molecule promotes functionally adapted Tregs in a preclinical model of type 1 diabetes Article Snippet: To investigate the in vitro effects of SAR’336 (Sanofi) on Tregs, purified CD4 + GFP + Tregs (GFP + , 50 × 10 3 ) from B6.FoxP3 GFPki female mice were activated in 96-well, flat-bottomed (0.2 mL) plates previously coated with α-CD3 (3 μg/mL) and α-CD28 (2 μg/mL), in the presence of Article Title: Genetically engineered macrophages persist in solid tumors and locally deliver therapeutic proteins to activate immune responses Article Snippet: T cells were stimulated with Dynabeads and cultured in RPMI-1640 (Gibco) with 10% FBS (VWR Seradigm), 2 mM l-glutamine (Gibco), 0.5 ng/mL rhIL-15 (Miltenyi Biotec) and either 50 U/mL Article Title: Cancer-Initiating Cells from Colorectal Cancer Patients Escape from T Cell–Mediated Immunosurveillance In Vitro through Membrane-Bound IL-4 Article Snippet: IL-4 neutralization can augment the proliferation of MLTCs stimulated with autologous CICs Isolation of CRC-reactive T lymphocytes PBMCs from the peripheral blood of CRC patients (#1076, 1247, and 14583) were cultured in vitro in the presence of autologous irradiated (300 Gy) colorectal CICs or, when available, FBS tumor cells, pretreated or not with rhIFN-γ (1000 IU/ml; PeproTech), with 100 IU/ml Article Title: Cancer-Initiating Cells from Colorectal Cancer Patients Escape from T Cell–Mediated Immunosurveillance In Vitro through Membrane-Bound IL-4 Article Snippet: PBMCs from the peripheral blood of CRC patients (#1076, 1247, and 14583) were cultured in vitro in the presence of autologous irradiated (300 Gy) colorectal CICs or, when available, FBS tumor cells, pretreated or not with rhIFN-γ (1000 IU/ml; PeproTech), with 100 IU/ml Article Title: Genetically engineered macrophages persist in solid tumors and locally deliver therapeutic proteins to activate immune responses. Article Snippet: T cells were stimulated with Dynabeads and cultured in RPMI-1640 (Gibco) with 10% FBS (VWR Seradigm), 2 mM l- glutamine (Gibco), 0.5 ng/mL rhIL-15 (Miltenyi Biotec) and either 50 U/ mL Article Title: Modulation of SRSF2 expression reverses the exhaustion of TILs via the epigenetic regulation of immune checkpoint molecules Article Snippet: In brief, a single tumor fragment was placed in individual wells of a Neutralization:Article Title: Evolution of melanoma cross-resistance to CD8 + T cells and MAPK inhibition in the course of BRAFi treatment Article Snippet: Expansion of TILs was achieved by culturing suspension cells from tumor tissue in RPMI 1640 supplemented with 10% Article Title: The IL-2 SYNTHORIN molecule promotes functionally adapted Tregs in a preclinical model of type 1 diabetes. Article Snippet: To investigate the in vitro effects of SAR’336 (Sanofi) on Tregs, purified CD4+GFP+ Tregs (GFP+, 50 × 103) from B6.FoxP3GFPki female mice were activated in 96-well, flat-bottomed (0.2 mL) plates previously coated with α-CD3 (3 μg/mL) and α-CD28 (2 μg/mL), in the presence of Article Title: The IL-2 SYNTHORIN molecule promotes functionally adapted Tregs in a preclinical model of type 1 diabetes Article Snippet: To investigate the in vitro effects of SAR’336 (Sanofi) on Tregs, purified CD4 + GFP + Tregs (GFP + , 50 × 10 3 ) from B6.FoxP3 GFPki female mice were activated in 96-well, flat-bottomed (0.2 mL) plates previously coated with α-CD3 (3 μg/mL) and α-CD28 (2 μg/mL), in the presence of Article Title: Genetically engineered macrophages persist in solid tumors and locally deliver therapeutic proteins to activate immune responses Article Snippet: T cells were stimulated with Dynabeads and cultured in RPMI-1640 (Gibco) with 10% FBS (VWR Seradigm), 2 mM l-glutamine (Gibco), 0.5 ng/mL rhIL-15 (Miltenyi Biotec) and either 50 U/mL Article Title: Cancer-Initiating Cells from Colorectal Cancer Patients Escape from T Cell–Mediated Immunosurveillance In Vitro through Membrane-Bound IL-4 Article Snippet: IL-4 neutralization can augment the proliferation of MLTCs stimulated with autologous CICs Isolation of CRC-reactive T lymphocytes PBMCs from the peripheral blood of CRC patients (#1076, 1247, and 14583) were cultured in vitro in the presence of autologous irradiated (300 Gy) colorectal CICs or, when available, FBS tumor cells, pretreated or not with rhIFN-γ (1000 IU/ml; PeproTech), with 100 IU/ml Article Title: Cancer-Initiating Cells from Colorectal Cancer Patients Escape from T Cell–Mediated Immunosurveillance In Vitro through Membrane-Bound IL-4 Article Snippet: PBMCs from the peripheral blood of CRC patients (#1076, 1247, and 14583) were cultured in vitro in the presence of autologous irradiated (300 Gy) colorectal CICs or, when available, FBS tumor cells, pretreated or not with rhIFN-γ (1000 IU/ml; PeproTech), with 100 IU/ml Article Title: Genetically engineered macrophages persist in solid tumors and locally deliver therapeutic proteins to activate immune responses. Article Snippet: T cells were stimulated with Dynabeads and cultured in RPMI-1640 (Gibco) with 10% FBS (VWR Seradigm), 2 mM l- glutamine (Gibco), 0.5 ng/mL rhIL-15 (Miltenyi Biotec) and either 50 U/ mL Article Title: Modulation of SRSF2 expression reverses the exhaustion of TILs via the epigenetic regulation of immune checkpoint molecules Article Snippet: In brief, a single tumor fragment was placed in individual wells of a Isolation:Article Title: Evolution of melanoma cross-resistance to CD8 + T cells and MAPK inhibition in the course of BRAFi treatment Article Snippet: Expansion of TILs was achieved by culturing suspension cells from tumor tissue in RPMI 1640 supplemented with 10% Article Title: The IL-2 SYNTHORIN molecule promotes functionally adapted Tregs in a preclinical model of type 1 diabetes. Article Snippet: To investigate the in vitro effects of SAR’336 (Sanofi) on Tregs, purified CD4+GFP+ Tregs (GFP+, 50 × 103) from B6.FoxP3GFPki female mice were activated in 96-well, flat-bottomed (0.2 mL) plates previously coated with α-CD3 (3 μg/mL) and α-CD28 (2 μg/mL), in the presence of Article Title: The IL-2 SYNTHORIN molecule promotes functionally adapted Tregs in a preclinical model of type 1 diabetes Article Snippet: To investigate the in vitro effects of SAR’336 (Sanofi) on Tregs, purified CD4 + GFP + Tregs (GFP + , 50 × 10 3 ) from B6.FoxP3 GFPki female mice were activated in 96-well, flat-bottomed (0.2 mL) plates previously coated with α-CD3 (3 μg/mL) and α-CD28 (2 μg/mL), in the presence of Article Title: Genetically engineered macrophages persist in solid tumors and locally deliver therapeutic proteins to activate immune responses Article Snippet: T cells were stimulated with Dynabeads and cultured in RPMI-1640 (Gibco) with 10% FBS (VWR Seradigm), 2 mM l-glutamine (Gibco), 0.5 ng/mL rhIL-15 (Miltenyi Biotec) and either 50 U/mL Article Title: Cancer-Initiating Cells from Colorectal Cancer Patients Escape from T Cell–Mediated Immunosurveillance In Vitro through Membrane-Bound IL-4 Article Snippet: IL-4 neutralization can augment the proliferation of MLTCs stimulated with autologous CICs Isolation of CRC-reactive T lymphocytes PBMCs from the peripheral blood of CRC patients (#1076, 1247, and 14583) were cultured in vitro in the presence of autologous irradiated (300 Gy) colorectal CICs or, when available, FBS tumor cells, pretreated or not with rhIFN-γ (1000 IU/ml; PeproTech), with 100 IU/ml Article Title: Cancer-Initiating Cells from Colorectal Cancer Patients Escape from T Cell–Mediated Immunosurveillance In Vitro through Membrane-Bound IL-4 Article Snippet: PBMCs from the peripheral blood of CRC patients (#1076, 1247, and 14583) were cultured in vitro in the presence of autologous irradiated (300 Gy) colorectal CICs or, when available, FBS tumor cells, pretreated or not with rhIFN-γ (1000 IU/ml; PeproTech), with 100 IU/ml Article Title: Genetically engineered macrophages persist in solid tumors and locally deliver therapeutic proteins to activate immune responses. Article Snippet: T cells were stimulated with Dynabeads and cultured in RPMI-1640 (Gibco) with 10% FBS (VWR Seradigm), 2 mM l- glutamine (Gibco), 0.5 ng/mL rhIL-15 (Miltenyi Biotec) and either 50 U/ mL Article Title: Modulation of SRSF2 expression reverses the exhaustion of TILs via the epigenetic regulation of immune checkpoint molecules Article Snippet: In brief, a single tumor fragment was placed in individual wells of a Cell Culture:Article Title: Evolution of melanoma cross-resistance to CD8 + T cells and MAPK inhibition in the course of BRAFi treatment Article Snippet: Expansion of TILs was achieved by culturing suspension cells from tumor tissue in RPMI 1640 supplemented with 10% Article Title: The IL-2 SYNTHORIN molecule promotes functionally adapted Tregs in a preclinical model of type 1 diabetes. Article Snippet: To investigate the in vitro effects of SAR’336 (Sanofi) on Tregs, purified CD4+GFP+ Tregs (GFP+, 50 × 103) from B6.FoxP3GFPki female mice were activated in 96-well, flat-bottomed (0.2 mL) plates previously coated with α-CD3 (3 μg/mL) and α-CD28 (2 μg/mL), in the presence of Article Title: The IL-2 SYNTHORIN molecule promotes functionally adapted Tregs in a preclinical model of type 1 diabetes Article Snippet: To investigate the in vitro effects of SAR’336 (Sanofi) on Tregs, purified CD4 + GFP + Tregs (GFP + , 50 × 10 3 ) from B6.FoxP3 GFPki female mice were activated in 96-well, flat-bottomed (0.2 mL) plates previously coated with α-CD3 (3 μg/mL) and α-CD28 (2 μg/mL), in the presence of Article Title: Genetically engineered macrophages persist in solid tumors and locally deliver therapeutic proteins to activate immune responses Article Snippet: T cells were stimulated with Dynabeads and cultured in RPMI-1640 (Gibco) with 10% FBS (VWR Seradigm), 2 mM l-glutamine (Gibco), 0.5 ng/mL rhIL-15 (Miltenyi Biotec) and either 50 U/mL Article Title: Cancer-Initiating Cells from Colorectal Cancer Patients Escape from T Cell–Mediated Immunosurveillance In Vitro through Membrane-Bound IL-4 Article Snippet: IL-4 neutralization can augment the proliferation of MLTCs stimulated with autologous CICs Isolation of CRC-reactive T lymphocytes PBMCs from the peripheral blood of CRC patients (#1076, 1247, and 14583) were cultured in vitro in the presence of autologous irradiated (300 Gy) colorectal CICs or, when available, FBS tumor cells, pretreated or not with rhIFN-γ (1000 IU/ml; PeproTech), with 100 IU/ml Article Title: Cancer-Initiating Cells from Colorectal Cancer Patients Escape from T Cell–Mediated Immunosurveillance In Vitro through Membrane-Bound IL-4 Article Snippet: PBMCs from the peripheral blood of CRC patients (#1076, 1247, and 14583) were cultured in vitro in the presence of autologous irradiated (300 Gy) colorectal CICs or, when available, FBS tumor cells, pretreated or not with rhIFN-γ (1000 IU/ml; PeproTech), with 100 IU/ml Article Title: Genetically engineered macrophages persist in solid tumors and locally deliver therapeutic proteins to activate immune responses. Article Snippet: T cells were stimulated with Dynabeads and cultured in RPMI-1640 (Gibco) with 10% FBS (VWR Seradigm), 2 mM l- glutamine (Gibco), 0.5 ng/mL rhIL-15 (Miltenyi Biotec) and either 50 U/ mL Article Title: Modulation of SRSF2 expression reverses the exhaustion of TILs via the epigenetic regulation of immune checkpoint molecules Article Snippet: In brief, a single tumor fragment was placed in individual wells of a Irradiation:Article Title: Evolution of melanoma cross-resistance to CD8 + T cells and MAPK inhibition in the course of BRAFi treatment Article Snippet: Expansion of TILs was achieved by culturing suspension cells from tumor tissue in RPMI 1640 supplemented with 10% Article Title: The IL-2 SYNTHORIN molecule promotes functionally adapted Tregs in a preclinical model of type 1 diabetes. Article Snippet: To investigate the in vitro effects of SAR’336 (Sanofi) on Tregs, purified CD4+GFP+ Tregs (GFP+, 50 × 103) from B6.FoxP3GFPki female mice were activated in 96-well, flat-bottomed (0.2 mL) plates previously coated with α-CD3 (3 μg/mL) and α-CD28 (2 μg/mL), in the presence of Article Title: The IL-2 SYNTHORIN molecule promotes functionally adapted Tregs in a preclinical model of type 1 diabetes Article Snippet: To investigate the in vitro effects of SAR’336 (Sanofi) on Tregs, purified CD4 + GFP + Tregs (GFP + , 50 × 10 3 ) from B6.FoxP3 GFPki female mice were activated in 96-well, flat-bottomed (0.2 mL) plates previously coated with α-CD3 (3 μg/mL) and α-CD28 (2 μg/mL), in the presence of Article Title: Genetically engineered macrophages persist in solid tumors and locally deliver therapeutic proteins to activate immune responses Article Snippet: T cells were stimulated with Dynabeads and cultured in RPMI-1640 (Gibco) with 10% FBS (VWR Seradigm), 2 mM l-glutamine (Gibco), 0.5 ng/mL rhIL-15 (Miltenyi Biotec) and either 50 U/mL Article Title: Cancer-Initiating Cells from Colorectal Cancer Patients Escape from T Cell–Mediated Immunosurveillance In Vitro through Membrane-Bound IL-4 Article Snippet: IL-4 neutralization can augment the proliferation of MLTCs stimulated with autologous CICs Isolation of CRC-reactive T lymphocytes PBMCs from the peripheral blood of CRC patients (#1076, 1247, and 14583) were cultured in vitro in the presence of autologous irradiated (300 Gy) colorectal CICs or, when available, FBS tumor cells, pretreated or not with rhIFN-γ (1000 IU/ml; PeproTech), with 100 IU/ml Article Title: Cancer-Initiating Cells from Colorectal Cancer Patients Escape from T Cell–Mediated Immunosurveillance In Vitro through Membrane-Bound IL-4 Article Snippet: PBMCs from the peripheral blood of CRC patients (#1076, 1247, and 14583) were cultured in vitro in the presence of autologous irradiated (300 Gy) colorectal CICs or, when available, FBS tumor cells, pretreated or not with rhIFN-γ (1000 IU/ml; PeproTech), with 100 IU/ml Article Title: Genetically engineered macrophages persist in solid tumors and locally deliver therapeutic proteins to activate immune responses. Article Snippet: T cells were stimulated with Dynabeads and cultured in RPMI-1640 (Gibco) with 10% FBS (VWR Seradigm), 2 mM l- glutamine (Gibco), 0.5 ng/mL rhIL-15 (Miltenyi Biotec) and either 50 U/ mL Article Title: Modulation of SRSF2 expression reverses the exhaustion of TILs via the epigenetic regulation of immune checkpoint molecules Article Snippet: In brief, a single tumor fragment was placed in individual wells of a |